explore -WSS

explore

author：leisure time 2025-09-05 13:30:43 - browse：38

Adam's take main illustration — Molly Ferguson/STAT

Cassava Sciences has long claimed its experimental drug, called simufilam, slows the cognitive decline of people with Alzheimer’s. On Friday, we learned how: The company recruited a large number of people into its clinical trial who don’t have Alzheimer’s.

People who almost certainly had Alzheimer’s were also included in the study, but in this group, a placebo outperformed Cassava’s drug.

The conclusion, of course, is obvious: Simufilam is inactive. It’s an inert compound no more effective than a placebo. Cassava’s assertion that simufilam is showing “disease-modifying activity” falls apart given its study was opened to people who should have been ineligible because they were misdiagnosed with Alzheimer’s. Whether that was done intentionally or unwittingly isn’t known, but it’s certainly troubling and makes the case for immediate, regulatory intervention even stronger.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： What is the Turing Test that determines if computers can think?

hotspot

WSS

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Mindstrong's demise and the future of mental health care

Inequities make cancer less preventable for women: report

WHO recommends dropping component of many flu vaccines

Trump Organization, Michael Cohen agree to settle million

WHO recommends dropping component of many flu vaccines

hotspot

explore

focus

Continuity nursing helped my family in our darkest PICU moments

How one patient went off dialysis — and others can too

Wildfire smoke exposes gaps in outdoor worker protections

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

After a drawn out lobbying fight, ARPA

Peter Hotez and the public health issue of online harassment

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Tori Bowie and the unacceptable rates of Black maternal death

New chief aims to remake Sanofi Genzyme

explore

Intercept Pharmaceuticals sells itself for less than $1 billion

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Shingles, which affected Dianne Feinstein, is on the rise

New chief aims to remake Sanofi Genzyme

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Listen: BridgeBio's big week & Lilly's Alzheimer's data

entertainment

hotspot

hotspot

hotspot